Advertisement
New Zealand markets open in 39 minutes
  • NZX 50

    11,698.51
    -166.38 (-1.40%)
     
  • NZD/USD

    0.6132
    -0.0012 (-0.20%)
     
  • ALL ORDS

    7,943.60
    -31.20 (-0.39%)
     
  • OIL

    80.62
    +2.17 (+2.77%)
     
  • GOLD

    2,333.60
    -15.50 (-0.66%)
     

Rapid Microbiology Testing Kits Global Market Report 2023

ReportLinker
ReportLinker

Major players in the rapid microbiology testing kits market are Abbott Laboratories, Becton, Dickinson and Company, Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Don Whitley Scientific Limited, Merck KGaA, Neogen Corporation, Quidel Corporation, and Rapid Micro Biosystems Inc.

New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Rapid Microbiology Testing Kits Global Market Report 2023" - https://www.reportlinker.com/p06280845/?utm_source=GNW


The global rapid microbiology testing kits market is expected to grow from $4.10 billion in 2021 to $4.36 billion in 2022 at a compound annual growth rate (CAGR) of 6.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The rapid microbiology testing kits market is expected to grow to $5.28 billion in 2026 at a CAGR of 4.9%.

The rapid microbiology testing market includes revenues earned by entities by qualitative, quantitative, and identification methods.The market value includes the value of related goods sold by the service provider or included within the service offering.

Only goods and services traded between entities or sold to end consumers are included.

Rapid microbiology testing has high sensitivity and less turnover time compared to traditional methods and is used to diagnose infectious diseases or target products by examining pathogens within a short period.

North America was the largest region in the rapid microbiology testing kits market in 2022.Western Europe was the second largest region in the rapid microbiology testing kits market.

The regions covered in rapid microbiology testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The main product types of rapid microbiology testing kits are instruments, reagents, kits, consumables. The various testing types included are growth-based rapid microbiology testing kits, cellular component-based rapid microbiology testing kits, nucleic acid-based rapid microbiology testing kits, viability-based rapid microbiology testing kits, and other rapid microbiology testing kits methods that are used for applications such as clinical disease diagnosis, food, and beverage testing, pharmaceutical and biological drug testing, cosmetics and personal care products testing, environmental testing, research applications, and others.

The rising number of infectious diseases is one of the major drivers for the rapid microbiology testing kits market.Rapid diagnostic tests are faster, more reliable, and more widely available than traditional tests.

As the number of infectious disease cases increases, the need for tests to confirm these diseases also increases.With the increasing demand for microbiology tests, the need for rapid microbiology tests is increasing as it gives quicker results than normal microbiology tests.

For example, according to the Centers for Disease Control and Prevention (CDC) Trusted Source, the number of visits to physician offices with infectious and parasitic diseases as the primary diagnosis was 15.5 million and the number of emergency department visits with infectious and parasitic diseases as the primary diagnosis was 3.7 million per year.

The stringent regulations related to rapid microbiology testing kits are a major restraint for the market.This is because scientific validation is a critical part of obtaining regulatory approval for a rapid microbiology testing method.

In this regard, various tests such as a test for accuracy, specificity, precision, range, and robustness are mandatory.The processes for evaluating, validating, and implementing rapid microbiology test methods are expensive and time-consuming.

This often leads to a delay in the launch of a testing method and adds up to the final cost of the test. For example, the process for approval by the FDA for rapid microbiology testing methods is very time-consuming which alters the normal operating cycle for manufacturers and causes a delay in the commercial launch of the test devices in the market.

Technological advancements are an emerging trend in the rapid microbiology testing kits market.This is mainly because these technological advancements improve the reliability and efficiency of tests and testing methods.

Automation in rapid microbial detection enables higher throughputs and greater accuracy in results.Similarly, robotic cassette handling, incubation, and imaging reduce the risks of miscounts, mid-test contamination, and incorrect data entry, which leads to fewer false positives and out-of-specification investigations.

Fewer investigations then ultimately improve uptime and reduce delay and recall of tests. For example, Abbott Laboratories announced the next generation Alinity HQ Hematology Analyzer that is aimed to minimize errors and reduce manual steps in testing.

The FDA regulates rapid microbiology testing through its process analytical technology (PAT) regulatory framework initiative.PAT is a system that evaluates the designing, controlling, and timely measuring of critical quality of raw and processed materials.

It seems that manufacturers have built-in quality into products rather than testing quality in products.This ensures final product quality and improves manufacturing efficiencies.

Hence, regulations such as these would keep a check on the companies in the rapid microbiology testing market.

The countries covered in the rapid microbiology testing kits market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The rapid microbiology testing kits market research report is one of a series of new reports that provides rapid microbiology testing kits market statistics, including rapid microbiology testing kits industry global market size, regional shares, competitors with a rapid microbiology testing kits market share, detailed rapid microbiology testing kits market segments, market trends and opportunities, and any further data you may need to thrive in the rapid microbiology testing kits industry. This rapid microbiology testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Read the full report: https://www.reportlinker.com/p06280845/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001